Tau Takes the Lead: The Next Battlefield in Alzheimer’s Treatment at AAIC 2026
At AAIC 2026, tau emerges as the new focal point in Alzheimer's research, overshadowing amyloid. A correction from Eli Lilly on its tau-targeted drug highlights...
Enter your email to receive a secure code. No password needed.
